The United Kingdom nasal spray market growth is set to progress at a CAGR of 9.20% during the forecast period, 2021-2026. Respiratory diseases are the third major cause of death in the UK. These include chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and lung cancer.

UNITED KINGDOM NASAL SPRAY MARKET FORECAST 2021-2026

United States Nasal Spray Market by Product (Decongestion Nasal Spray, Steroid Nasal Spray, Saltwater Solution/saline Nasal Spray) Market by Prescription (Over the Counter, Prescribed) Market by Therapeutic (Antihistamine, Nasal Steroids, Anticholinergic, Mast Cell Inhibitor) Market by Application (Nasal Congestion, Allergic and Non-allergic Rhinitis, Vaccination, CNS Disorders, Other Applications) Market by End-user (Home Care Setting, ASC/clinics, Pharmacy, Hospital, Other End-users)

Request free sample

The United Kingdom nasal spray market growth is set to progress at a CAGR of 9.20% during the forecast period, 2021-2026. Respiratory diseases are the third major cause of death in the UK. These include chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and lung cancer.united-kingdom-nasal-spray-market

To learn more about this report, request a free sample copy

In the United Kingdom, allergic rhinitis (AR) is a common condition in children and is gaining prevalence. 10% of 6-7-year-olds have AR. The peak onset is in adolescents and children. The AR management depends on the severity of symptoms, for which nasal sprays are recommended. For instance, antihistamines are taken as nasal sprays.

Moreover, respiratory diseases are on the rise. This is also attributed to exposure to higher levels of air pollution, high smoking rates, occupational hazards, and poor housing conditions. As a result, COPD and asthma contribute significantly to mortalities in the UK. Further, chronic rhinosinusitis (CRS) is another prevalent condition in 10% of the adult population. It is associated with high healthcare utilization and a considerable reduction of quality of life.

GlaxoSmithKline (GSK) is a science-led healthcare company with three businesses developing, researching, and manufacturing vaccines, consumer healthcare products, and pharmaceutical medicines. It develops vaccines against infectious diseases. In addition, the product portfolio includes medicines for oncology, immune-inflammation, HIV, and respiratory. The company has operations in the Americas, Asia-Pacific, Europe, Africa, etc., with headquarters in Brentford, Middlesex, the UK.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
    3. KEY ANALYTICS
      • IMPACT OF COVID-19 ON NASAL SPRAY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
    4. MARKET BY PRODUCT
      • DECONGESTION NASAL SPRAY
      • STEROID NASAL SPRAY
      • SALTWATER SOLUTION/SALINE NASAL SPRAY
    5. MARKET BY PRESCRIPTION
      • OVER THE COUNTER
      • PRESCRIBED
    6. MARKET BY THERAPEUTIC
      • ANTIHISTAMINE
      • NASAL STEROIDS
      • ANTICHOLINERGIC
      • MAST CELL INHIBITOR
    7. MARKET BY APPLICATION
      • NASAL CONGESTION
      • ALLERGIC AND NON-ALLERGIC RHINITIS
      • VACCINATION
      • CNS DISORDERS
      • OTHER APPLICATIONS
    8. MARKET BY END-USER
      • HOME CARE SETTING
      • ASC/CLINICS
      • PHARMACY
      • HOSPITAL
      • OTHER END-USERS
    9. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • ASTRAZENECA
        • GLAXOSMITHKLINE PLC
        • JOHNSON & JOHNSON
        • PROCTOR & GAMBLE CO (P&G)
        • SANOFI SA

    LIST OF TABLES  

    TABLE 1: MARKET SNAPSHOT – NASAL SPRAY

    TABLE 2: UNITED KINGDOM NASAL SPRAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: UNITED KINGDOM NASAL SPRAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 4: UNITED KINGDOM NASAL SPRAY MARKET, BY PRESCRIPTION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: UNITED KINGDOM NASAL SPRAY MARKET, BY PRESCRIPTION, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 6: UNITED KINGDOM NASAL SPRAY MARKET, BY THERAPEUTIC, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: UNITED KINGDOM NASAL SPRAY MARKET, BY THERAPEUTIC, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 8: UNITED KINGDOM NASAL SPRAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: UNITED KINGDOM NASAL SPRAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 10: UNITED KINGDOM NASAL SPRAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: UNITED KINGDOM NASAL SPRAY MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 12: LIST OF MERGERS & ACQUISITIONS

    TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

    LIST OF FIGURES 

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: UNITED KINGDOM NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020

    FIGURE 5: UNITED KINGDOM NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2026 (IN $ MILLION)

    FIGURE 6: UNITED KINGDOM NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2026 (IN $ MILLION)

    FIGURE 7: UNITED KINGDOM NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2026 (IN $ MILLION)

    FIGURE 8: UNITED KINGDOM NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRESCRIPTION, IN 2020

    FIGURE 9: UNITED KINGDOM NASAL SPRAY MARKET, BY OVER THE COUNTER, 2021-2026 (IN $ MILLION)

    FIGURE 10: UNITED KINGDOM NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2026 (IN $ MILLION)

    FIGURE 11: UNITED KINGDOM NASAL SPRAY MARKET, GROWTH POTENTIAL, BY THERAPEUTIC, IN 2020

    FIGURE 12: UNITED KINGDOM NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2026 (IN $ MILLION)

    FIGURE 13: UNITED KINGDOM NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2026 (IN $ MILLION)

    FIGURE 14: UNITED KINGDOM NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2026 (IN $ MILLION)

    FIGURE 15: UNITED KINGDOM NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2026 (IN $ MILLION)

    FIGURE 16: UNITED KINGDOM NASAL SPRAY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

    FIGURE 17: UNITED KINGDOM NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2026 (IN $ MILLION)

    FIGURE 18: UNITED KINGDOM NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2026 (IN $ MILLION)

    FIGURE 19: UNITED KINGDOM NASAL SPRAY MARKET, BY VACCINATION, 2021-2026 (IN $ MILLION)

    FIGURE 20: UNITED KINGDOM NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2026 (IN $ MILLION)

    FIGURE 21: UNITED KINGDOM NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2026 (IN $ MILLION)

    FIGURE 22: UNITED KINGDOM NASAL SPRAY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 23: UNITED KINGDOM NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2026 (IN $ MILLION)

    FIGURE 24: UNITED KINGDOM NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2026 (IN $ MILLION)

    FIGURE 25: UNITED KINGDOM NASAL SPRAY MARKET, BY PHARMACY, 2021-2026 (IN $ MILLION)

    FIGURE 26: UNITED KINGDOM NASAL SPRAY MARKET, BY HOSPITAL, 2021-2026 (IN $ MILLION)

    FIGURE 27: UNITED KINGDOM NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2026 (IN $ MILLION)

    1. MARKET BY PRODUCT
      • DECONGESTION NASAL SPRAY
      • STEROID NASAL SPRAY
      • SALTWATER SOLUTION/SALINE NASAL SPRAY
    2. MARKET BY PRESCRIPTION
      • OVER THE COUNTER
      • PRESCRIBED
    3. MARKET BY THERAPEUTIC
      • ANTIHISTAMINE
      • NASAL STEROIDS
      • ANTICHOLINERGIC
      • MAST CELL INHIBITOR
    4. MARKET BY APPLICATION
      • NASAL CONGESTION
      • ALLERGIC AND NON-ALLERGIC RHINITIS
      • VACCINATION
      • CNS DISORDERS
      • OTHER APPLICATIONS
    5. MARKET BY END-USER
      • HOME CARE SETTING
      • ASC/CLINICS
      • PHARMACY
      • HOSPITAL
      • OTHER END-USERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type